The effect of probiotic supplementation Lactobacillus Rhamnosus (RC-14) and Lactobacillus Reuteri ( GR-1) on increasing the number of CD4 in HIV patients, A double blind randomized clinical trial with a placebo control.

Vice chancellor for research Tehran University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新: 2018年2月22日

适应症

试验速览

暂无简介。

•Confirm HIV infection by Western blot analysis; lack of criteria for initiating treatment according to national HIV guideline; no use of probiotic supplements in the past 6 months ; have a consent to conduct research Exclusion criteria:On Highly Active Anti Retroviral Therapy (HAART) regimens; active addiction; opportunistic infection in the past; Liver or Kidney failure; inflammatory bowel disease and other well known Gastrointestinal pathology; active infection and fever; younger than 18 and older than 65 years; have a cancer, pregnancy and breastfeeding; being dependent on alcohol; a history of allergy or sensitivity to the probiotic or lactose intolerance; use of other supplement drugs, and multivitamins; Use of growth hormone, testosterone or anabolic agent during the last 6 months.

发起方

Vice chancellor for research Tehran University of Medical Sciences